Scarica l'app Stockscreener
49.87
8.73%
-4.77
Dopo l'orario di chiusura:
49.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$54.64
Aprire:
$53.16
Volume 24 ore:
6.76M
Relative Volume:
2.81
Capitalizzazione di mercato:
$7.82B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
53.05
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-13.59%
1M Prestazione:
-6.15%
6M Prestazione:
-33.52%
1 anno Prestazione:
-36.41%
Intervallo 1D:
$47.66
$54.56
Intervallo di 1 settimana:
$47.66
$57.74
Portata 52W:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
49.87 | 8.57B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio-Techne (TECH) Q4 EPS Rises 8.2% - The Motley Fool
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bio-Techne's Q4 Fiscal 2025 Results Trigger 6.5% Share DeclineNews and Statistics - IndexBox
Why Bio-Techne (TECH) Shares Are Plunging Today - Yahoo Finance
Earnings call transcript: Bio-Techne Q4 2025 beats EPS forecasts - Investing.com
Bio-Techne Q2 2025 Financial Results: Revenue and EPS Surpass ExpectationsNews and Statistics - IndexBox
Bio-Techne Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations - Yahoo Finance
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls - Nasdaq
Bio-Techne Exceeds Forecasts And Refines Its Focus On Growth - Finimize
Bio-Techne Q4 25 Earnings Conference Call At 9:00 AM ET - Nasdaq
Techne (TECH) Beats Q4 Earnings and Revenue Estimates - Nasdaq
Bio-Techne Corp (TECH) Q4 Earnings: Revenue Surpasses Estimates - GuruFocus
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Bio-techne declares quarterly dividend of $0.08 per share - Investing.com
Bio-Techne Earnings Beat Estimates as Cell Therapy Division Drives Growth, Strategic Divestiture Announced - Stock Titan
Dividend Alert: Bio-Techne Sets $0.08 Per Share Payout, Reveals August Payment Timeline - Stock Titan
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com South Africa
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? - MSN
Stock Analysis | Bio-Techne OutlookWeak Technicals but Strong Fundamentals - AInvest
Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow - Yahoo Finance
Why is Bio Techne Corporation stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News
What drives Bio Techne Corporation stock priceExponential wealth increase - Jammu Links News
When is Bio Techne Corporation stock expected to show significant growthGain insights from top financial experts - Jammu Links News
Is Bio Techne Corporation stock overvalued or undervaluedMassive profits - Jammu Links News
How strong is Bio Techne Corporation company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
Bio Techne Corporation Shows Risk Reward Favoring UpsideAccurate Buy Point for Momentum Stocks Detected - beatles.ru
Is it the right time to buy Bio Techne Corporation stockAI Powered Growth Plan For 2025 - Jammu Links News
Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending - Yahoo Finance
Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns - Yahoo Finance
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering - Yahoo Finance
Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher - TipRanks
Will Bio Techne Corporation stock benefit from interest rate changesLow Risk High Return Opportunities Identified - beatles.ru
Momentum Screeners Rank Bio Techne Corporation in Top 5 TodayReal-Time Trade Insights Spark Market Reactions - metal.it
Why Bio Techne Corporation is moving today Weekly Setup Summary for Risk Controlled Trades - metal.it
How many analysts rate Bio Techne Corporation as a “Buy”Discover the fastest growing stocks today - Jammu Links News
Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen - Insider Monkey
What makes Bio Techne Corporation stock price move sharplyAchieve rapid capital gains with smart investing - Jammu Links News
Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH) - Yahoo Finance
Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - MSN
10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey
Bio-Techne Corporation (TECH): A Bull Case Theory - Yahoo Finance
What analysts say about Bio Techne Corporation stockTriple returns potential - jammulinksnews.com
Bio-Techne (TECH) Stock Is Up, What You Need To Know - Yahoo Finance
Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional
Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):